Lymphoma, Large Cell Completed Phase 1 / 2 Trials for Spanlecortemlocel (DB17130)

Also known as: Large Cell Lymphoma / Lymphoma, Large-Cell / Large-cell Lymphoma

IndicationStatusPhase
DBCOND0032452 (Lymphoma, Large Cell)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01474681Safety and Tolerability of HSC835 in Patients With Hematological MalignanciesTreatment